Related Experiment Video
Updated: Jan 21, 2026

12:18
Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
23.6K
Vancomycin Treatment Failure in Children With Methicillin-Resistant Staphylococcus aureus Bacteremia
Summary
Vancomycin treatment failure for invasive MRSA infections in children was lower than expected. Achieving high vancomycin AUC24/MIC ratios did not guarantee treatment success, suggesting current targets may not apply to pediatric patients.
Area of Science:
- Pediatric Infectious Diseases
- Pharmacokinetics and Pharmacodynamics
- Antimicrobial Stewardship
Background:
- Invasive methicillin-resistant Staphylococcus aureus (MRSA) infections pose a significant challenge in pediatric populations.
- Vancomycin is a primary treatment, but clinical outcomes and optimal dosing strategies in children remain under-investigated.
- Established treatment success metrics in adults, such as the area under the curve/minimum inhibitory concentration (AUC24/MIC) ratio ≥400, have not been validated in pediatric MRSA infections.
Purpose of the Study:
- To evaluate the clinical outcomes of invasive MRSA infections in children treated with vancomycin.
- To determine the utility of the AUC24/MIC ratio ≥400 as a predictor of treatment success in pediatric patients.
- To investigate the relationship between vancomycin dosing, trough concentrations, AUC24/MIC ratios, and treatment outcomes.
Main Methods:
- Retrospective chart review of pediatric patients receiving vancomycin for MRSA bacteremia for at least 5 days.
- Estimation of AUC24/MIC ratios using two distinct vancomycin clearance equations.
- Definition of vancomycin treatment failure as persistent bacteremia (≥7 days), recurrent bacteremia within 30 days, or 30-day mortality.
Main Results:
- Out of 67 bacteremia episodes, 13.4% met treatment failure criteria.
- Higher vancomycin doses (≥60 mg/kg/day) increased the likelihood of achieving AUC24/MIC ratios ≥400.
- No significant differences in median dose, trough concentrations, or AUC24/MIC ratios were observed between treatment success and failure groups.
Conclusions:
- The rate of vancomycin treatment failure for pediatric MRSA bacteremia was lower than previously reported.
- Achieving AUC24/MIC ratios ≥400 was common but not associated with improved treatment outcomes, dose, or trough levels.
- Further prospective studies with standardized definitions are necessary to elucidate vancomycin treatment failure in pediatric MRSA bacteremia.
More Related Videos
Related Concept Videos
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
596
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
596
Resistivity
4.4K
When a voltage is applied to a conductor, an electrical field is generated, and charges in the conductor feel the force due to the electrical field. The current density that results depends on the electrical field and the properties of the material. In some materials, including metals at a given temperature, the current density is approximately proportional to the electrical field. In these cases, the current density can be modeled as:
4.4K
Resistance
5.7K
When a current moves through any conductor, the conductor causes some level of difficulty for the current to flow. The measure of that difficulty is known as the resistance of the material and is represented by R. Every material has its own resistance. In the case of conductors, heat is emitted whenever a current passes through them. Resistance depends on the resistivity of the material. Resistivity is a characteristic of the material used to fabricate electrical components, whereas the...
5.7K
Pathophysiology of Heart Failure
3.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.0K
Heart Failure I: Introduction
723
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
723

